This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

R. L. Bloomfield, MD, MS; C. F. Pedley, MD; M. Leonard, MD
Bowman Gray School of Medicine Winston-Salem, NC

JAMA. 1997;277(10):788.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The article by Dr Grossman and colleagues¹ regarding recommendations for sublingual nifedipine uses the term "pseudoemergency." Unfortunately, this term is not common in the hypertensive literature, and its use suggests that there are primarily 2 clinical situations: true and false hypertensive emergencies. On the other hand, the term "urgency" suggests that the clinician has thoughtfully assessed the patient's condition and feels that the blood pressure elevation should be classified in a less-than-emergency category.

Moreover, the authors should consider some useful alternatives, such as oral captopril, which are noted in textbooks on hypertension.^2,3 Another alternative is to use a lower dose of short-acting nifedipine, especially in elderly patients.⁴

Some of the potential adverse effects of an otherwise effective therapy may be avoidable by a knowledge of the dose-response relationship. This may be true with diuretics, β-blockers, angiotensin-converting enzyme inhibitors, aspirin, digoxin, and calcium channel blockers, as well as . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?